Detalhe da pesquisa
1.
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.
N Engl J Med
; 388(10): 898-912, 2023 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36884323
2.
A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours.
Br J Cancer
; 130(7): 1131-1140, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38287179
3.
Complete tumor necrosis after neoadjuvant chemotherapy defines good responders in patients with Ewing sarcoma.
Cancer
; 129(1): 60-70, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36305090
4.
Molecular Advances in the Treatment of Advanced Gastrointestinal Stromal Tumor.
Oncologist
; 28(8): 671-681, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37315115
5.
A Rare Presentation of Aggressive Renal Cell Carcinoma and the Utility of Early Molecular Testing in Rapidly Progressing Malignancies: A Case Report.
Oncologist
; 28(12): 1094-1099, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37844295
6.
Prognostic Significance of Percentage and Size of Dedifferentiation in Dedifferentiated Chondrosarcoma.
Mod Pathol
; 36(3): 100069, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788104
7.
The NIH pediatric/young adult chordoma clinic and natural history study: Making advances in a very rare tumor.
Pediatr Blood Cancer
; : e30358, 2023 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37347686
8.
Phase II Study of Cabozantinib in Patients With Bone Metastasis.
Oncologist
; 27(7): 600-606, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35524758
9.
Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network.
Oncologist
; 27(11): 930-939, 2022 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35852437
10.
Case 20-2023: A 52-Year-Old Man with a Solitary Fibrous Tumor and Hypoglycemia.
N Engl J Med
; 388(26): 2467-2477, 2023 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37379139
11.
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study.
Lancet Oncol
; 21(11): 1423-1432, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33035459
12.
Next-Generation Sequencing for Patients with Sarcoma: A Single Center Experience.
Oncologist
; 23(2): 234-242, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28860410
13.
A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers.
Oncologist
; 23(6): 658-e72, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29511132
14.
Clinicopathologic characteristics of poorly differentiated chordoma.
Mod Pathol
; 31(8): 1237-1245, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29483606
15.
Case 36-2019: A 34-Year-Old Man with Dyspnea, Odynophagia, and Abdominal Pain.
N Engl J Med
; 381(21): 2052-2061, 2019 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31747731
16.
Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma.
Cancer
; 121(8): 1223-30, 2015 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25536954
17.
Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy.
BMC Cancer
; 14: 813, 2014 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25374341
18.
Safety And Efficacy Of Combination Lurbinectedin Plus Doxorubicin From A Phase 1b Trial In Patients With Advanced/Metastatic Soft Tissue Sarcoma.
Clin Cancer Res
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38723278
19.
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates.
Clin Cancer Res
; 30(7): 1281-1292, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38236580
20.
ATR inhibitor, camonsertib, dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study).
J Natl Cancer Inst
; 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38710487